FR2309223B1 - - Google Patents

Info

Publication number
FR2309223B1
FR2309223B1 FR7612778A FR7612778A FR2309223B1 FR 2309223 B1 FR2309223 B1 FR 2309223B1 FR 7612778 A FR7612778 A FR 7612778A FR 7612778 A FR7612778 A FR 7612778A FR 2309223 B1 FR2309223 B1 FR 2309223B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7612778A
Other languages
French (fr)
Other versions
FR2309223A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of FR2309223A1 publication Critical patent/FR2309223A1/fr
Application granted granted Critical
Publication of FR2309223B1 publication Critical patent/FR2309223B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7612778A 1975-04-30 1976-04-29 Nouveaux ethers et thioethers de 1-aryl-2-(1-imidazolyl)alkyle, leur procede de preparation et composition pharmaceutique les contenant Granted FR2309223A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1792275A GB1475271A (en) 1975-04-30 1975-04-30 1-aryl-2-1-imidazolyl-alkyl ethers and thioethers and their use as antifungal agents

Publications (2)

Publication Number Publication Date
FR2309223A1 FR2309223A1 (fr) 1976-11-26
FR2309223B1 true FR2309223B1 (de) 1978-08-25

Family

ID=10103597

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7612778A Granted FR2309223A1 (fr) 1975-04-30 1976-04-29 Nouveaux ethers et thioethers de 1-aryl-2-(1-imidazolyl)alkyle, leur procede de preparation et composition pharmaceutique les contenant

Country Status (35)

Country Link
US (1) US4062966A (de)
JP (1) JPS51133266A (de)
AR (1) AR212592A1 (de)
AT (1) AT350551B (de)
BE (1) BE841309A (de)
BG (1) BG25517A3 (de)
CA (1) CA1063123A (de)
CH (1) CH605930A5 (de)
CS (1) CS191302B2 (de)
DD (1) DD124983A5 (de)
DE (1) DE2619381C3 (de)
DK (1) DK147682C (de)
EG (1) EG12222A (de)
ES (1) ES447525A1 (de)
FI (1) FI64157C (de)
FR (1) FR2309223A1 (de)
GB (1) GB1475271A (de)
GR (1) GR60383B (de)
HK (1) HK61979A (de)
HU (1) HU174210B (de)
IE (1) IE43272B1 (de)
IL (1) IL49406A (de)
LU (1) LU74866A1 (de)
MX (1) MX3240E (de)
MY (1) MY8000109A (de)
NL (1) NL162911C (de)
NO (1) NO143970C (de)
PH (1) PH12906A (de)
PL (1) PL104365B1 (de)
PT (1) PT65045B (de)
RO (1) RO72609A (de)
SE (1) SE418860B (de)
SU (1) SU622405A3 (de)
YU (1) YU40646B (de)
ZA (1) ZA762036B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1511390A (en) * 1975-12-04 1978-05-17 Pfizer Ltd Imidazolylalkyl sulphide antifungal agents
EP0001654B1 (de) * 1977-10-13 1981-07-22 Siegfried Aktiengesellschaft Imidazolyläthyl-oxyalkoxy-Derivate und ihre Thio-Analoge, pharmazeutische Zubereitungen mit diesen Stoffen und Verfahren zu ihrer Herstellung
IT1096361B (it) * 1978-05-18 1985-08-26 Recordati Chem Pharm Dibenzileteri sostituiti terapeuticamente attivi
US4272545A (en) * 1979-02-02 1981-06-09 Syntex (U.S.A.) Inc. Derivatives of thienyl- and furyl-substituted N-butyl and N-phenyl imidazoles
US4307105A (en) * 1979-07-05 1981-12-22 E. R. Squibb & Sons, Inc. Imidazolylethoxymethyl derivatives of thiazole
US4315023A (en) * 1979-09-06 1982-02-09 Westwood Pharmaceuticals, Inc. 1-Phenethylimidazole derivatives
US4248881A (en) * 1979-12-20 1981-02-03 E. R. Squibb & Sons, Inc. Imidazolylethoxymethyl derivatives of pyrazole
CA1155853A (en) * 1980-06-06 1983-10-25 Joseph A. Martin Imidazole derivatives and preparation thereof
US4458079A (en) * 1980-08-08 1984-07-03 Bristol-Myers Company Sulfur-containing imidazoles
ES8504779A1 (es) * 1984-02-02 1985-05-01 Ferrer Int Procedimiento de obtencion de nuevos derivados de 1h-imidazol
US4766140A (en) * 1984-06-18 1988-08-23 Eli Lilly And Company Method of inhibiting aromatase
IT1200422B (it) * 1985-03-19 1989-01-18 Ripari Gero Ist Farm Biolog Composto con attivita' antimicrobia,sua preparazione e composizioni farmaceutiche che lo contengono
DE3932552A1 (de) * 1989-09-29 1991-04-11 Basf Ag Verfahren zur herstellung von 1-hydroxyimidazol
US5270032A (en) * 1990-10-04 1993-12-14 The Research Foundation Of State University Of New York Composition and method for the prevention and treatment of candidiasis
US5399552A (en) * 1991-10-17 1995-03-21 Merck & Co, Inc Antibiotic peptides bearing aminoalkylthioether moieties
US6545163B1 (en) * 1995-10-02 2003-04-08 Napp Technologies Process to prepare 1-aryl-2-(1-imidazolyl) alkyl ethers and thioethers
CN101519403B (zh) * 2009-04-08 2012-05-30 广东工业大学 一种合成噻康唑的方法
BRPI0904249B1 (pt) 2009-08-28 2018-03-06 Biolab Sanus Farmacêutica Ltda. Compostos éteres aralquil benzílicos, processo de preparação dos mesmos, uso dos referidos compostos, composição farmacêutica
US11185548B2 (en) 2016-12-23 2021-11-30 Helmholtz Zentrum Munchen—Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases
CN110537545A (zh) * 2019-09-12 2019-12-06 青岛农业大学 噻康唑在制备用于防治植物病原菌的杀菌剂中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354173A (en) * 1964-04-16 1967-11-21 Janssen Pharmaceutica Nv Imidazole carboxylates
US3575999A (en) * 1968-08-19 1971-04-20 Janssen Pharmaceutica Nv Ketal derivatives of imidazole
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
LU60908A1 (de) * 1969-05-21 1970-07-16
US3658813A (en) * 1970-01-13 1972-04-25 Janssen Pharmaceutica Nv 1-(beta-aryl-beta-(r-oxy)-ethyl)-imidazoles
DE2059949C3 (de) * 1970-12-05 1979-12-13 Bayer Ag, 5090 Leverkusen Thienyl-fettsäurederivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2359922A1 (de) * 1973-12-01 1975-06-05 Hoechst Ag (1-alkyl-5-nitro-imidazolyl-2-alkyl)- heteroaryl-verbindungen und verfahren zu ihrer herstellung
DE2362171A1 (de) * 1973-12-14 1975-06-26 Hoechst Ag (1-alkyl-5-nitro-imidazolyl-2-alkyl)heteroaryl-verbindungen und verfahren zu ihrer herstellung
US3991202A (en) * 1974-01-31 1976-11-09 Janssen Pharmaceutica N.V. Imidazolium salts

Also Published As

Publication number Publication date
FR2309223A1 (fr) 1976-11-26
IE43272B1 (en) 1981-01-28
AU1319976A (en) 1977-03-31
FI761200A (de) 1976-10-31
PT65045B (en) 1977-09-13
HU174210B (hu) 1979-11-28
ZA762036B (en) 1977-04-27
DE2619381B2 (de) 1977-10-06
NL162911C (nl) 1980-07-15
CS191302B2 (en) 1979-06-29
DK147682C (da) 1985-07-15
ES447525A1 (es) 1977-07-01
MY8000109A (en) 1980-12-31
FI64157B (fi) 1983-06-30
SU622405A3 (ru) 1978-08-30
MX3240E (es) 1980-08-06
YU40646B (en) 1986-04-30
DK147682B (da) 1984-11-12
NO761481L (de) 1976-11-02
GB1475271A (en) 1977-06-01
NL7604583A (nl) 1976-11-02
JPS51133266A (en) 1976-11-18
LU74866A1 (de) 1977-12-02
DD124983A5 (de) 1977-03-23
SE7604975L (sv) 1976-10-31
GR60383B (en) 1978-05-24
BG25517A3 (en) 1978-10-10
DK154776A (da) 1976-10-31
AT350551B (de) 1979-06-11
DE2619381C3 (de) 1980-10-16
CH605930A5 (de) 1978-10-13
SE418860B (sv) 1981-06-29
AR212592A1 (es) 1978-08-15
ATA310276A (de) 1978-11-15
PT65045A (en) 1976-05-01
NL162911B (nl) 1980-02-15
US4062966A (en) 1977-12-13
NO143970B (no) 1981-02-09
YU100976A (en) 1982-06-30
PL104365B1 (pl) 1979-08-31
IL49406A (en) 1979-09-30
FI64157C (fi) 1983-10-10
RO72609A (ro) 1982-02-01
HK61979A (en) 1979-09-07
IE43272L (en) 1976-10-30
BE841309A (fr) 1976-10-29
CA1063123A (en) 1979-09-25
NO143970C (no) 1981-05-20
DE2619381A1 (de) 1976-11-11
JPS5331872B2 (de) 1978-09-05
EG12222A (en) 1978-09-30
PH12906A (en) 1979-10-04
IL49406A0 (en) 1976-06-30

Similar Documents

Publication Publication Date Title
FR2316254B1 (de)
FR2309223B1 (de)
JPS5215542B2 (de)
JPS5612740B2 (de)
JPS51154715U (de)
JPS5210652U (de)
JPS5244035U (de)
JPS5238747U (de)
JPS553977Y2 (de)
JPS5327311B2 (de)
JPS5257153Y2 (de)
JPS522275U (de)
JPS5263850U (de)
JPS5276829U (de)
CH596331A5 (de)
CH598169A5 (de)
CH595917A5 (de)
CH595939A5 (de)
CH595486A5 (de)
CH595948A5 (de)
CH601636A5 (de)
CH592012A5 (de)
CH596506A5 (de)
CH597101A5 (de)
CH594811A5 (de)

Legal Events

Date Code Title Description
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0370, 920602

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0369, 760429

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0370, 760429

CL Concession to grant licences